Lorazepam Treatment May Be Linked to Worse Outcomes for Pancreatic Cancer Patients
PHILADELPHIA – Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer...
PHILADELPHIA – Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer...
PHILADELPHIA – The transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered...
Article provides timely information following new law that will require trial sponsors to submit Diversity Action Plans to FDA...
PHILADELPHIA – First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic...
Researchers partnered with Gift of Life Michigan to analyze healthy pancreata from deceased donors PHILADELPHIA – Pancreatic intraepithelial neoplasia...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Christine A. Iacobuzio-Donahue, MD, PhD,...
Treatment consisted of high-dose abatacept, ruxolitinib, and proactive monitoring for respiratory muscle involvement PHILADELPHIA – Among cancer patients who...
Study reports five-year survival outcomes PHILADELPHIA – Patients with resectable non-small cell lung cancer (NSCLC) who were treated with...
Researchers identified mutational signatures characteristic of chemotherapy exposure PHILADELPHIA – Researchers identified a higher rate of clonal hematopoiesis (CH)...
Responses to the off-the-shelf therapy were observed in 95 percent of patients PHILADELPHIA – Posoleucel, an investigational allogeneic off-the-shelf...